Last €79.18 EUR
Change Today +0.90 / 1.15%
Volume 0.0
IC7 On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 1:03 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

icu medical inc (IC7) Snapshot

Open
€79.02
Previous Close
€78.28
Day High
€79.27
Day Low
€78.58
52 Week High
02/27/15 - €79.27
52 Week Low
05/7/14 - €38.57
Market Cap
1.2B
Average Volume 10 Days
76.8
EPS TTM
--
Shares Outstanding
15.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ICU MEDICAL INC (IC7)

icu medical inc (IC7) Related Businessweek News

No Related Businessweek News Found

icu medical inc (IC7) Details

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient’s vein for use in hospitals and ambulatory clinics. The company’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave clear, anti-microbial MicroClave, neutrons, NanoClave, and Clave; custom infusion sets; and Tego needlefree hemodialysis connectors. It also provides critical care products used to monitor signs, as well as physiological functions of organ systems. The company’s critical care products comprises hemodynamic monitoring systems, including Transpac disposable pressure transducers, Safeset closed needlefree blood conservation systems, and custom monitoring systems; sensor, pulmonary artery thermodilution, central venous oximetry, and multi-lumen central venous catheters; custom angiography and interventional radiology kits; and Lopez enteral valves. In addition, it offers a line of oncology products that are used to prepare and deliver hazardous medications used in chemotherapy, such as ChemoLock and ChemoClave closed system transfer device and components, and Diana hazardous drug compounding system. The company sells its products to medical product manufacturers, independent distributors, and directly to end users. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

2,280 Employees
Last Reported Date: 02/20/15
Founded in 1984

icu medical inc (IC7) Top Compensated Officers

Chief Financial Officer, Treasurer and Secret...
Total Annual Compensation: $406.6K
Vice President of Operations
Total Annual Compensation: $399.4K
Vice President and General Manager of Infusio...
Total Annual Compensation: $315.0K
Compensation as of Fiscal Year 2013.

icu medical inc (IC7) Key Developments

ICU Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Fiscal Year of 2015

ICU Medical, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the full year, the company reported net sales of $308,770,000 compared to $313,056,000 a year ago. Total revenue was $309,260,000 compared to $313,716,000 a year ago. Income from operations was $39,037,000 compared to $51,949,000 a year ago. Income before income taxes was $39,792,000 compared to $52,714,000 a year ago. Net income was $26,335,000 compared to $40,418,000 a year ago. Diluted net income per share was $1.68 compared to $2.65 a year ago. Net cash provided by operating activities was $60,640,000 compared to $65,726,000 a year ago. Purchases of property and equipment were $16,604,000 compared to $18,415,000 a year ago. Intangible asset additions were $989,000 compared to $1,080,000 a year ago. Adjusted EBITDA was $73,924,000 compared to $79,024,000 a year ago. Adjusted diluted earnings per share were $2.38 compared to $3.06 a year ago. For the fourth quarter, the company reported net sales of $79,773,000 compared to $77,637,000 a year ago. Total revenue was $79,896,000 compared to $77,941,000 a year ago. Income from operations was $12,053,000 compared to $13,558,000 a year ago. Income before income taxes was $12,236,000 compared to $13,753,000 a year ago. Net income was $7,372,000 compared to $13,332,000 a year ago. Diluted net income per share was $0.46 compared to $0.86 a year ago. Adjusted EBITDA was $21,896,000 compared to $20,138,000 a year ago. Adjusted diluted earnings per share were $0.68 compared to $0.94 a year ago. The company provided earnings guidance for the fiscal year of 2015. For the period, the company expects revenue to be in the range of $312 million to $317 million; GAAP diluted earnings per share to be in the range of $2.15 to $2.25, adjusted diluted earnings per share to be in the range of $2.70 to $2.80, and adjusted EBITDA to be in the range of $84 million to $86 million.

ICU Medical, Inc. to Report Q4, 2014 Results on Feb 09, 2015

ICU Medical, Inc. announced that they will report Q4, 2014 results at 4:00 PM, US Eastern Standard Time on Feb 09, 2015

ICU Medical, Inc., Q4 2014 Earnings Call, Feb 09, 2015

ICU Medical, Inc., Q4 2014 Earnings Call, Feb 09, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IC7:GR €79.18 EUR +0.90

IC7 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $18.60 USD -0.32
Cyberonics Inc $68.50 USD +1.90
Masimo Corp $29.47 USD -0.43
NxStage Medical Inc $17.18 USD -0.93
Wright Medical Group Inc $24.63 USD +0.13
View Industry Companies
 

Industry Analysis

IC7

Industry Average

Valuation IC7 Industry Range
Price/Earnings 52.8x
Price/Sales 4.5x
Price/Book 2.7x
Price/Cash Flow 52.8x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICU MEDICAL INC, please visit www.icumed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.